NCT02320448View on ClinicalTrials.gov

Treating Peritoneal Carcinomatosis With PIPAC

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Peritoneal Carcinomatosis
Interventions
DRUG

PIPAC

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Michael Bau Mortensen

OTHER

NCT02320448 - Treating Peritoneal Carcinomatosis With PIPAC | Biotech Hunter | Biotech Hunter